Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

SELL
$224.99 - $256.14 $232,189 - $264,336
-1,032 Reduced 22.91%
3,473 $833,000
Q1 2023

Apr 11, 2023

BUY
$239.75 - $277.0 $52,745 - $60,940
220 Added 5.13%
4,505 $1.14 Million
Q4 2022

Feb 07, 2023

BUY
$241.42 - $282.29 $105,017 - $122,796
435 Added 11.3%
4,285 $1.14 Million
Q3 2022

Oct 17, 2022

BUY
$247.06 - $1507.4 $222,848 - $1.36 Million
902 Added 30.6%
3,850 $977,000
Q2 2022

Jul 12, 2022

BUY
$237.11 - $299.66 $51,215 - $64,726
216 Added 7.91%
2,948 $782,000
Q1 2022

Apr 07, 2022

BUY
$257.27 - $315.76 $702,861 - $862,656
2,732 New
2,732 $801,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track My Legacy Advisors, LLC Portfolio

Follow My Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of My Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on My Legacy Advisors, LLC with notifications on news.